Introduction
Methods
Design
Study population
Instruments
General health status
Disease-specific health status
Physical mobility
Care dependency
Statistics
Results
General patient characteristics
COPD (n = 105) | CHF (n = 80) | |
---|---|---|
Gender (male), n (%) | 65 (61.9%) | 54 (67.5%) |
Age (years), mean (SD) | 66.3 (9.2)* | 76.2 (8.3) |
BMI (kg/m2), mean (SD)#
| 26.3 (6.7)* | 28.6 (5.6) |
Marital status (married/living with partner), n (%) | 78 (74.3%)* | 45 (56.3%) |
Current smokers, n (%) | 26 (24.8%)* | 11 (13.8%) |
FEV1 (% predicted), mean (SD)#
| 34.1 (13.5)* | 75.5 (24.5) |
Charlson index (pts), mean (SD) | 2.5 (1.7)* | 4.4 (2.0) |
Long-term oxygen therapy, n (%) | 62 (59.0%)*
| 10 (12.5%) |
Need for professional caregiver, n (%) | 23 (21.9%)* | 32 (40.0%) |
Family caregiver, n (%) | 90 (85.7%) | 61 (76.3%) |
Number of symptoms, mean (SD) | 8.1 (3.7) | 9.1 (3.5) |
Borg scale (points), mean (SD) | 4.8 (2.0)* | 4.0 (2.5) |
HADS-A score (points), mean (SD) | 5.9 (4.5) | 5.6 (4.3) |
HADS-D score (points), mean (SD) | 6.3 (4.0) | 6.9 (4.0) |
Number of physician-prescribed drugs, mean (SD)#
| 8.5 (3.9)* | 10.8 (3.7) |
General health status
COPD (n = 105) | CHF (n = 80) | ||
---|---|---|---|
EQ-5D index score, mean (SD) | 0.51 (0.33) | 0.47 (0.32) | |
EQ-5D VAS, mean (SD)#
| 62.6 (14.0) | 62.1 (13.5) | |
EQ-5D Mobility, n (%) | No problems | 16 (15.2%) | 8 (10.0%) |
Some problems | 87 (82.9%) | 69 (86.2%) | |
Extreme problems | 2 (1.9%) | 3 (3.8%) | |
EQ-5D Self-care, n (%) | No problems | 43 (41.0%) | 27 (33.8%) |
Some problems | 50 (47.6%) | 38 (47.4%) | |
Extreme problems | 12 (11.4%) | 15 (18.8%) | |
EQ-5D Usual activities, n (%) | No problems | 18 (17.1%) | 12 (15.0%) |
Some problems | 61 (58.1%) | 50 (62.5%) | |
Extreme problems | 26 (24.8%) | 18 (22.5%) | |
EQ-5D Pain/discomfort*, n (%) | No problems | 57 (54.3%) | 29 (36.2%) |
Some problems | 38 (36.2%) | 43 (53.8%) | |
Extreme problems | 10 (9.5%) | 8 (10.0%) | |
EQ-5D Anxiety/depression, n (%) | No problems | 62 (59.1%) | 44 (55.0%) |
Some problems | 33 (31.4%) | 29 (36.2%) | |
Extreme problems | 10 (9.5%) | 7 (8.8%) |
COPD (n = 105) | CHF (n = 80) | |
---|---|---|
AQoL illness | 0.17 (0.17) | 0.18 (0.14) |
AQoL independent living | 0.58 (0.30) | 0.50 (0.30) |
AQoL social relationships
#
| 0.83 (0.20) | 0.78 (0.27) |
AQoL physical senses
#
| 0.92 (0.11)* | 0.84 (0.15) |
AQoL psychological well-being
#
| 0.87 (0.13) | 0.85 (0.15) |
AQoL total | 0.46 (0.28)* | 0.35 (0.26) |
Disease-specific health status
Care dependency
Correlates of general health status
Model | Correlates | Standardized Beta |
P value |
---|---|---|---|
EQ-5D index score (R
2 = 0.564, P < 0.0005) | Number of symptoms | −0.149 | 0.022 |
TUG test | −0.228 | 0.000 | |
HADS-A | −0.182 | 0.007 | |
HADS-D | −0.033 | 0.640 | |
Borg scale | −0.096 | 0.083 | |
CDS | 0.253 | 0.000 | |
Need professional caregiver | −0.157 | 0.006 | |
Number of drugs | −0.124 | 0.024 | |
AQol total score (R
2 = 0.661, P < 0.0005) | Number of symptoms | −0.192 | 0.001 |
TUG test | −0.006 | 0.914 | |
HADS-A | −0.072 | 0.228 | |
HADS-D | −0.170 | 0.006 | |
Borg scale | −0.086 | 0.078 | |
CDS | 0.347 | 0.000 | |
Need professional caregiver | −0.225 | 0.000 | |
Number of drugs | −0.137 | 0.005 |
Correlates of disease-specific health status
Model | Correlates | Standardized beta |
P value | |
---|---|---|---|---|
COPD n = 104* | SGRQ total score (R
2 = 0.575, P < 0.0005) | Number of symptoms | 0.259 | 0.003 |
HADS-A | −0.027 | 0.768 | ||
HADS-D | 0.213 | 0.018 | ||
Borg scale | 0.358 | 0.000 | ||
CDS | −0.225 | 0.004 | ||
CHF n = 80 | MLHFQ total score (R
2 = 0.529, P < 0.0005) | Number of symptoms | 0.251 | 0.020 |
HADS-A | 0.311 | 0.005 | ||
HADS-D | 0.074 | 0.511 | ||
Borg scale | 0.165 | 0.076 | ||
CDS | −0.212 | 0.020 |